Table 2.
Variables | Aorta group (n = 56) | ITA group (n = 47) | LAA group (n = 23) | p-value |
---|---|---|---|---|
Operative data | ||||
Operating time, mean ± SD min | 254.6 ± 72.2 | 213.7 ± 57.6 | 253 ± 81.2 | 0.008 |
Total grafts average, mean ± SD | 2.5 ± 0.6 | 2.2 ± 0.4 | 2.2 ± 0.6 | 0.015 |
The average number of distal anastomoses, mean ± SD | 2.9 ± 0.9 | 2.4 ± 0.7 | 2.9 ± 1.1 | 0.014 |
None touch aorta, n (%) | 0 (0) | 47 (100) | 21 (91.3) | <0.001 |
Complete revascularization, n (%) | 54 (96.4) | 42 (89.4) | 21 (91.3) | 0.363 |
Over two atrial graft, n (%) | 8 (14.3) | 7 (14.9) | 3 (13.0) | 0.979 |
Graft, n (%) | ||||
LITA | 53 (94.6) | 47 (100) | 22 (95.7) | 0.285 |
RITA | 3 (5.4) | 6 (12.8) | 2 (8.7) | 0.415 |
Radial artery | 6 (10.7) | 0 (0) | 2 (8.7) | 0.075 |
Postoperative outcome | ||||
ICU stay, median [IQR] days | 2 [1–2] | 1 [1–2] | 2 [1–2] | 0.350 |
Hospital stay, median [IQR] days | 6 [5–7] | 6 [5–7] | 5 [5–6] | 0.727 |
Extubation within 24 h, n (%) | 52 (92.9) | 44 (93.6) | 22 (95.7) | 0.898 |
Perioperative transfusion, n (%) | 36 (64.3) | 24 (51.1) | 13 (56.5) | 0.395 |
Drain contents, median [IQR] ml | 350 [300–550] | 340 [240–500] | 460 [280–600] | 0.240 |
30-day mortality, n (%) | 0 (0) | 1 (2.1) | 0 (0) | 0.429 |
Postoperative complications, n (%) | ||||
New stroke | 0 (0) | 1 (2.1) | 0 (0) | 0.429 |
New dialysis | 0 (0) | 0 (0) | 0 (0) | |
New onset atrial fibrillation | 14 (25.0) | 7 (14.9) | 9 (39.1) | 0.079 |
Wound infection | 0 (0) | 0 (0) | 0 (0) | |
Reoperation of bleeding | 2 (3.6) | 1 (2.1) | 1 (4.3) | 0.861 |
MACCE long-term, n (%) | 1 (1.8) | 5 (10.6) | 2 (8.7) | 0.163 |
Cardiac death | 0 (0) | 3 (4.3) | 0 (0) | 0.076 |
Stroke | 0 (0) | 1 (2.1) | 1 (4.3) | 0.348 |
Hear failure requiring hospitalization | 0 (0) | 0 (0) | 0 (0) | |
Postoperative myocardial infarction | 1 (1.8) | 1 (2.1) | 1 (4.3) | 0.786 |
Repeat revascularization | 1 (1.8) | 0 (0) | 0 (0) | 0.533 |
LITA, left internal thoracic artery; RITA, right internal thoracic artery; ICU, intensive care unit; MACCE, major adverse cardiac or cerebrovascular events.